BMEZ
BlackRock Health Sciences Trust II [BMEZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BMEZ Stock Summary
Top BMEZ Correlated Resources
BMEZ
Top 10 Correlated ETFs
BMEZ
Top 10 Correlated Stocks
BMEZ
In the News
BMEZ Financial details
Company Rating
-
Market Cap
1.61B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
1.58
Dividend %
10.51%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
0.57
P/C
-
P/FCF
15.17
Quick Ratio
0.23
Current Ratio
0.23
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-6.35%
SMA50
-12.72%
SMA100
-9.5%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
12.93-16.77
52W High
-8.19%
52W Low
+22.42%
RSI
57.22
Rel Volume
0.85
Avg Volume
332.73K
Volume
282.39K
Perf Week
8.98%
Perf Month
-2.59%
Perf Quarter
-5.95%
Perf Half Y
-5.53%
-
-
-
-
Beta
-
-
-
Volatility
0.3%, 0.6%
Prev Close
2.8%
Price
14.69
Change
4.11%
BMEZ Financial Performance
BMEZ Frequently Asked Questions
What is BlackRock Health Sciences Trust II stock symbol ?
BlackRock Health Sciences Trust II is a US stock , located in New york of Ny and trading under the symbol BMEZ
What is BlackRock Health Sciences Trust II stock quote today ?
BlackRock Health Sciences Trust II stock price is $14.69 today.
Is BlackRock Health Sciences Trust II stock public?
Yes, BlackRock Health Sciences Trust II is a publicly traded company.
Company Profile
- Volume Average 332.73K
- Market Capitalization 1.61B
- CEO Mr. Jeffrey Gene Lee
- Headquarters New York,NY,US
- IPO Date 2020-01-29
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
